Ignite Creation Date:
2024-05-06 @ 6:55 PM
Last Modification Date:
2024-10-26 @ 2:57 PM
Study NCT ID:
NCT05836584
Status:
RECRUITING
Last Update Posted:
2024-07-08
First Post:
2023-04-26
Brief Title:
Testing Immunotherapy Atezolizumab With or Without Chemotherapy in Locoregional MSI-HdMMR Gastric and Gastroesophageal Junction GEJ Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Clinical Stage I Gastric Cancer AJCC v8 |
| Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8 |
| Clinical Stage II Gastric Cancer AJCC v8 |
| Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8 |
| Clinical Stage III Gastric Cancer AJCC v8 |
| Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 |
| Clinical Stage IVA Gastric Cancer AJCC v8 |
| Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8 |
| Gastric Adenocarcinoma |
| Gastroesophageal Junction Adenocarcinoma |
Keywords: